返回
Ascentage Pharma Group International（6855.HK）价格
6855.HK 股价走势图
ASCENTAGE-B (6855.HK)
Ascentage Pharma Group International
HK$49.06
-1.28%
$-0.64
盘中： Jan 29, 09:55:49 HKT
关键数据
前收盘价
$49.3
开盘价
$49.7
当日区间
$48.52 - $49.7
52周范围
$31.35 - $95.35
交易量
17.0K
平均成交量
1.9M
每股收益（TTM）
-4.01
股息收益率
--
市值
$18.2B
什么是 ASCENTAGE-B？
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
